The usefulness of self-measurements of blood pressure (BP) at home (home BP measurements) in hypertensive patients has been reported by many studies. Several national guidelines recommend the use of home BP measurements to achieve better hypertension control. The objective of this study was to clarify the association between home BP measurements and hypertension treatment among 2363 essential hypertensive patients taking antihypertensive drugs. Compared to the 543 (23.0%) patients who had not taken home BP measurements, the 1820 (77.0%) patients who had taken home BP measurements were significantly older, included a higher proportion of males, included a higher proportion with a family history of hypertension, took a greater number of antihypertensive drugs and alpha blockers and took antihypertensive drugs more often in the evening. Home BP measurements were associated with significantly better control of home and office BP levels. Compared to patients who had not taken home BP measurements, the adjusted odds ratios for good control of morning home BPs, evening home BPs and office BPs in patients who had taken home BP measurements were 1.46 (95% confidential interval (CI) 1.33-1.57), 1.35 (95% CI 1.21-1.47) and 1.23 (95% CI 1.06-1.37), respectively. Home BP measurements were associated with good hypertensive management. Our findings suggest that it is important that physicians recommend home BP measurements to their patients.
Introduction
Adequate management of blood pressure (BP) in hypertensive patients is essential for preventing future cardiovascular events and for slowing progression to hypertensive complications. [1] [2] [3] However, BP control in hypertensive patients is poor worldwide. 4 Recently, several national guidelines have recommended the use of self-measurements of BP at home (home BP measurements) to better manage hypertension [5] [6] [7] [8] because of the many benefits associated with home BP measurements. [9] [10] [11] [12] [13] [14] However, home BP monitoring might not be appropriate for all patients, and some patients may not be able to measure their home BP because they have mental/physical disabilities, do not have enough time to take the measurements or may not be able to financially afford the device. Moreover, sometimes, home BP monitoring can cause anxiety to the patient. On the other hand, home BP measurements can eliminate the white coat effect, and are highly reproducible and useful for assessing the effect of antihypertensive treatment. 9, 12 It has also been shown that home BP measurements have a stronger predictive power for cardiovascular disease mortality and morbidity than BP measured in the office (office BP). 10, 11 Previous studies of essential hypertensive patients treated with antihypertensive medication have shown that compliance with antihypertensive medication and office BP levels is better among patients who regularly had taken home BP measurements than among those who had not. 13, 15 However, no data are available that have compared home BP control between patients who had taken home BP measurements and those who had not.
The objective of this study was to clarify the effects of taking home BP measurements on hypertension management based on data from the Japan Home vs Office BP Measurement Evaluation (J-HOME) study.
Methods

Design
The J-HOME study was conducted to measure BP control, as evaluated by home and office BP measurements, among essential hypertensive patients receiving antihypertensive treatment in primary care settings in Japan. The details of the J-HOME study have been described previously. 16, 17 The study protocol was approved by the Institutional Review Board of Tohoku University School of Medicine.
Patients
In March 2003, 7354 physicians were randomly selected from all over Japan and invited to take part in this project. Of the 1477 physicians who agreed to participate, 751 collected data for the study. By the end of August 2003, 3586 patients who gave their written informed consent to participate in the study were enrolled. Each doctor was asked to enrol five patients. Most doctors (79.3%) enrolled five patients or less (mean 4.7, median 5, mode 5, range . About half of the doctors enrolled five patients. Sixty-six patients were excluded because they were not taking antihypertensive medication. An additional 120 patients were excluded due to insufficient data regarding BP values or patient characteristics. Thus, the study population consisted of 3400 patients. Of the 3400 patients, information about whether the patients had taken home BP measurements at the time of recruitment into the J-HOME study was available for 2363 (69.5%) patients. There were no differences in the BP values or major characteristics between those for whom this information was available and those for whom it was not.
Home BP measurement
As specified by the Japanese guidelines for home BP measurements, patients were asked to measure their BP once every morning in the sitting position, within 1 h of waking, after more than 2 min of rest, but before drug ingestion and breakfast, and once every evening just before bedtime. The patients were asked to record their results over a 2-week period. 18 Before the beginning of the study, instruction leaflets regarding methods of home BP measurements were distributed by each doctor participating in the study to each patient. We asked the doctors to use the leaflets to teach their patients how to measure home BP and to include only those patients who were able to measure their home BP. The patients used electronic arm-cuff devices that operate on the basis of the cuff-oscillometric method. All such devices available in Japan have been validated and approved by the Ministry of Health, Labour, and Welfare, Japan. 19 The manufacturers of these devices were Omron Healthcare Co., Ltd (Kyoto, Japan), A&D Co., Ltd (Tokyo, Japan), Terumo Co., Ltd (Tokyo, Japan) and Matsushita Electric Works Ltd (Osaka, Japan). The actual model of each device was not provided by the doctors who were involved in the study. All devices used for home BP measurements in Japan are certified as having been adjusted to the Association for the Advancement of Medical Instrumentation (AAMI) standard. 19, 20 The mean of all measurements recorded over the 2-week period was calculated for each patient and used for the analysis.
Office BP measurement Office BPs were measured twice consecutively in the sitting position after a rest of at least 2 min at each regularly scheduled visit by physicians (81.0%) or nurses (19.0%). Office BPs were measured using either the auscultatory method with a mercury (75.1%) or an aneroid sphygmomanometer (3.3%), or with an electronic arm-cuff device based on the cuff-oscillometric method (21.6%), which had been validated and approved by the Ministry of Health, Labour, and Welfare, Japan. Furthermore, all automatic devices used in Japan are certified as having been adjusted to the AAMI standard. 20 The office BP value for each patient that was used for the analysis was defined as the average of four measurements taken at two office visits during the period when home measurements were being taken.
Data collection and statistical analysis
Information on patient characteristics, including whether they had taken home BP measurements, medication used and BP values, were collected by a questionnaire administered by the attending physician. Patients who were taking home BP measurements at the time of recruitment into the study were defined as 'patients who had taken home BP measurements.' On the other hand, patients who were not taking home BP measurements at the time of recruitment into the study were defined as 'patients who had not taken home BP measurements.' Study subjects entered a run-in period during which their medication remained unchanged and they continued to measure their home BP for 2 weeks if they had taken home BP measurements; patients who had not taken home BP measurements were asked by their physicians to measure their home BP. During this period, all patients had taken office BP measurements twice. Based on several guidelines, controlled home BP was defined as systolic BP o135 mm Hg and diastolic BP o85 mm Hg; [5] [6] [7] [8] 18 controlled office BP was defined as systolic BP o140 mm Hg and diastolic BP o90 mm Hg. [5] [6] [7] [8] The home BP control reference values for diabetic patients were tentatively set using the operational threshold; controlled home BP for diabetic patients was defined as systolic BP o130 mm Hg and diastolic BPo80 mm Hg. The reference values for office BP control in diabetic patients were the same as those recommended by several guidelines; controlled office BP was defined as systolic BPo130 mm Hg and diastolic BP o80 mm Hg. 5, 6 Variables were compared using Student's t-test and the w 2 -test as appropriate. Multivariate logistic regression analysis was used to adjust for between-group differences in patients' characteristics and antihypertensive treatment. Data are shown as mean ± standard deviation (s.d.). A P-value less than 0.05 was accepted as indicating statistical significance. All statistical analyses were conducted with SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).
Results
Patients' characteristics
The characteristics of the patients in both groups are shown in Table 1 . The mean morning home BPs, evening home BPs and office BPs were significantly lower in patients who had taken home BP measurements than in those who had not. Compared to patients who had not taken home BP measurements, patients who had taken home BP measurements were significantly older, included a higher proportion of males and included a higher proportion of those with a family history of hypertension.
Antihypertensive medication
The antihypertensive medications taken by patients in both groups are shown in Table 2 . Physicians prescribed alpha blockers more frequently to patients who had taken home BP measurements than to those who had not (15.0 vs 9.9%, P ¼ 0.003). The proportion of patients taking two or more antihypertensive drugs was significantly higher in patients who had taken home BP measurements than in those who had not (54.2 vs 47.2%, P ¼ 0.004). Moreover, patients who had taken home BP Abbreviations: BP, blood pressure; BMI, body mass index; HR, heart rate; CVD, cerebrovascular disease; IHD, ischaemic heart disease.
a Difference between patients who had taken home BP measurements and those who had not.
Home BP measurements and BP control T Obara et al measurements took their antihypertensive drugs in the evening (after dinner and before bedtime) more frequently than those who had not taken home BP measurements (34.5 vs 24.3%, Po0.0001). The frequency of taking antihypertensive drugs everyday was significantly higher in patients who had taken home BP measurements than in those who had not (P ¼ 0.0002). On multiple logistic analyses, older age, male gender, presence of a family history of hypertension and the use of alpha blockers were found to be significant and independent factors for patients who had taken home BP measurements (compared to those who had not taken home BP measurements) (all Po0.05). Figure 1 shows the proportions of patients in each group with properly controlled morning home BPs, evening home BPs and office BPs. The proportion of patients with properly controlled BP was higher among patients who had taken home BP measurements than among those who had not (Figure 1) . Although a similar tendency was observed when patients were grouped on the basis of the presence of diabetes mellitus (diabetes, n ¼ 322; no diabetes, n ¼ 2041) (Figure 1 ), there were no significant relationship between diabetes mellitus and taking home BP measurements with respect to good management of office BP (P40.7). Compared to patients who had not taken home BP measurements, the adjusted odds ratio (OR) for the presence of controlled morning home BPs, evening home BPs and office BPs in patients who had taken home BP measurements was 1.46 (95% confidence interval (CI) 1.33-1.57, Po0.0001) (adjusted for age, gender, body mass index, drinking status, and the number and class of antihypertensive drugs taken), 1.35 (95% CI 1.21-1.47, Po0.0001) (adjusted for age, body mass index, smoking status, history of cerebrovascular disease, ischaemic heart disease, diabetes, and the number and class of antihypertensive drugs taken) and 1.23 (95% CI 1.06-1.37, P ¼ 0.01) (adjusted for body mass index, history of cerebrovascular disease, ischaemic heart disease, diabetes, hypercholesterolaemia, and the class of antihypertensive drugs taken), respectively.
BP control
Discussion
Compared to the 543 (23.0%) patients who had not taken home BP measurements, the 1820 (77.0%) patients who had taken home BP measurements were significantly older, included a higher proportion of males, included a higher proportion of those who had a family history of hypertension, received a greater number of antihypertensive drugs, were more frequently given alpha blockers and more Difference between patients who had taken home BP measurements and those who had not.
Home BP measurements and BP control T Obara et al frequently took antihypertensive drugs in the evening. Taking home BP measurements was associated with significantly better home and office BP control. In several countries, the prevalence of patients who had taken home BP measurements among hypertensive patients has been reported to range from 19.7 to 87.3%. 15, [21] [22] [23] [24] In Japan, approximately 30 million home BP measuring devices have been distributed. 19 Additionally, both in the guidelines for self-measurement of BP at home 18 and in the Japanese Society of Hypertension Guidelines for the Management of Hypertension, 7 the Japanese Society of Hypertension strongly recommended that patients measure their own BP at home.
Patients' preference for home BP measurements might be affected by several factors, including their socioeconomic status, educational level, family environment, recommendation by physicians and others. In previous studies, compared to patients who had not taken home BP measurements, patients who had taken home BP measurements were younger, more often male and had a higher educational level or higher socioeconomic status. 15, 21 Taking home BP measurements might not be associated with socioeconomic status in Japan, since the socioeconomic status of the present population is essentially equivalent. Furthermore, in the present study, patients with a family history of hypertension were more likely to take home BP measurements. Patients with a family history of hypertension might be more concerned about their own BP levels than those without a family history of hypertension.
In the present study, it was found that, compared to patients who had not taken home BP measurements, patients who had taken home BP measurements received more aggressive therapy. It has been shown that the use of multiple drugs, the use of alpha blockers just before bedtime and the ingestion of antihypertensive drugs in the evening are useful for managing morning BP in hypertensive patients. 25 The Japanese Society of Hypertension Guidelines for the Management of Hypertension suggest that patients with an elevated morning BP should be given long-acting drugs and alpha blockers or centrally acting drugs just before going to bed. 7 In the present study, home and office BP control was better among patients who had taken home BP measurements than among those who had not taken home BP measurements. It seems that physicians who recommend home BP measurement might be more aware of the recent antihypertensive treatment studies and tend to treat hypertensive patients more aggressively than physicians who do not recommend home BP measurement.
Recently, many studies have reported the usefulness of home BP measurement in the management of hypertensive patients. 10, 11, 13, 14, [26] [27] [28] [29] [30] Staessen et al.
26
reported that home BP measurement resulted in reduction in the unnecessary use of antihypertensive drugs in white-coat hypertensive patients and led to better management of hypertension. On the other hand, in the present study, patients taking home BP measurements were on more medication. However, these results do not appear to suggest that patients who had taken home BP measurements were over-treated, since the proportion of patients with over-reduction of home BP in the morning (systolic BP o110 mm Hg and/or diastolic BP o60 mm Hg) was not different between patients who had taken home BP measurements (1.0%) and those who had not (1.3%) (P ¼ 0.55). Moreover, the study by Staessen et al. 26 was a prospective, randomized study, while the present study was a cross-sectional study. Therefore, the results of the two studies cannot be directly compared. Some studies have reported that home BP measurements might improve patients' drug compliance and increase physicians' concern about their patients' BP control by improving patients' compliance with hypertensive management and by increasing the availability of information on patients' BP. 28, 29 Halme et al. 30 found that intermittent self-measurement of BP improved BP control compared to ordinary treatment in a multicenter, randomized, parallel-group study in a primary health-care setting. Therefore, it appears that home BP measurements improve the management of hypertension. Although information to quantitatively evaluate the effect of home BP measurements on the improvement of BP control was not collected, self-measurement of BP at home by itself may be associated with the improvement of BP control, as suggested by previous studies. 13, 15 A previous study has shown that office BP levels were better controlled among patients who had regularly taken home BP measurements than among those who had not. 15 In the present study, it was found that patients who had taken home BP measurements received more aggressive therapy and that not only office BP control but also home BP control was better among patients who had taken home BP measurements than among those who had not taken home BP measurements. However, since the present study was a cross-sectional design, further studies that are designed to clarify whether home BP measurements improve patients' BP control are required. The office BP values, which were measured using a mercury sphygmomanometer (which introduces the possibility of observer's bias with respect to the BP readings), were compared with those measured with an electronic device between patients who had taken home BP measurements and those who had not. The office BP values measured by a mercury sphygmomanometer were significantly lower among patients who had taken home BP measurements (141.3 ± 13.5/ 79.7±8.9 mm Hg) than among those who had not (144.2 ± 14.6/82.4 ± 9.0 mm Hg) (P ¼ 0.0008/Po0.0001). These results did not change after adjustment for possible confounding factors. On the other hand, office BP values measured by an electronic device were not significantly different between patients who had taken home BP measurements (144.0 ± 16.1/80.7 ± 11.9 mm Hg) and those who had not (145.5 ± 14.6/84.4 ± 9.2 mm Hg) (P ¼ 0.42/ P ¼ 0.40). These results suggest that there might have been observer bias caused by awareness of the previous status of the patients' use of home BP measurements.
In conclusion, we found that home BP measurement was associated with good management of hypertensive patients. Our findings imply that it is important that physicians recommend home BP measurement to their patients. investigators independent of the sponsors. This study was conducted by the J-HOME Study Group.
